Supernus Pharmaceuticals (SUPN) Net Income Growth (5y) (2016 - 2025)
Supernus Pharmaceuticals (SUPN) Net Income Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn |
| 10 | Supernus Pharmaceuticals | 2.74 Bn | 2.35 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16.36% |
| Sep 30, 2025 | -25.62% |
| Mar 31, 2025 | -20.59% |
| Dec 31, 2024 | -14.29% |
| Sep 30, 2024 | 5.96% |
| Jun 30, 2024 | -9.47% |
| Mar 31, 2024 | -62.12% |
| Dec 31, 2023 | -46.13% |
| Sep 30, 2023 | -20.78% |
| Jun 30, 2023 | -15.18% |
| Mar 31, 2023 | -8.45% |
| Dec 31, 2022 | 13.31% |
| Sep 30, 2022 | -35.74% |
| Jun 30, 2022 | -14.65% |
| Mar 31, 2022 | 20.00% |
| Dec 31, 2021 | 15.91% |
| Sep 30, 2021 | -19.00% |
| Jun 30, 2021 | 18.27% |
| Mar 31, 2021 | 3.37% |
| Dec 31, 2020 | 35.04% |